The gift includes $10 million to a project to be named the Riccio ALS Accelerator Initiative and $5 million to expand and endow the Riccio Fund for Neuroscience. It is the third and largest donation to the school made by the Riccios.
“This extraordinary gift from the Riccios is transformational,” stated Robert Brown Jr., MD, professor of neurology and director of the program in neurotherapeutics at UMass Medical School. “It will greatly enhance the development of ALS therapies here at UMass Chan Medical School. With members of the RNA Therapeutics Institute, our team in neurology is developing new biologic treatments for ALS, targeting aspects of ALS gene expression.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
